Body mass index and risk of Alzheimer's disease: A mendelian randomization study of 399,536 individuals

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Body mass index and risk of Alzheimer's disease : A mendelian randomization study of 399,536 individuals. / Nordestgaard, Liv Tybjærg; Tybjærg-Hansen, Anne; Nordestgaard, Børge G.; Frikke-Schmidt, Ruth.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 102, No. 7, 07.2017, p. 2310-2320.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nordestgaard, LT, Tybjærg-Hansen, A, Nordestgaard, BG & Frikke-Schmidt, R 2017, 'Body mass index and risk of Alzheimer's disease: A mendelian randomization study of 399,536 individuals', Journal of Clinical Endocrinology and Metabolism, vol. 102, no. 7, pp. 2310-2320. https://doi.org/10.1210/jc.2017-00195

APA

Nordestgaard, L. T., Tybjærg-Hansen, A., Nordestgaard, B. G., & Frikke-Schmidt, R. (2017). Body mass index and risk of Alzheimer's disease: A mendelian randomization study of 399,536 individuals. Journal of Clinical Endocrinology and Metabolism, 102(7), 2310-2320. https://doi.org/10.1210/jc.2017-00195

Vancouver

Nordestgaard LT, Tybjærg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. Body mass index and risk of Alzheimer's disease: A mendelian randomization study of 399,536 individuals. Journal of Clinical Endocrinology and Metabolism. 2017 Jul;102(7):2310-2320. https://doi.org/10.1210/jc.2017-00195

Author

Nordestgaard, Liv Tybjærg ; Tybjærg-Hansen, Anne ; Nordestgaard, Børge G. ; Frikke-Schmidt, Ruth. / Body mass index and risk of Alzheimer's disease : A mendelian randomization study of 399,536 individuals. In: Journal of Clinical Endocrinology and Metabolism. 2017 ; Vol. 102, No. 7. pp. 2310-2320.

Bibtex

@article{731c8236579a4916b08d8ec87144a9d9,
title = "Body mass index and risk of Alzheimer's disease: A mendelian randomization study of 399,536 individuals",
abstract = "Context: Recently, data on 2,000,000 people established that low body mass index (BMI) is associated with increased risk of dementia. Whether this observational association reflects a causal effect remains to be clarified. Objective: Wetested the hypothesis that there is a causal association between low BMI and high risk of Alzheimer's disease. Design, Setting, and Participants: Using a Mendelian randomization approach, we studied 95,578 individuals from the Copenhagen General Population Study (CGPS) with up to 36 years of follow-up and consortia data on 303,958 individuals from the Genetic Investigation of Anthropometric Traits (GIANT) and the International Genomics of Alzheimer's Project (IGAP). Main Outcome Measure: Risk of Alzheimer's disease. Results: The causal odds ratio for a 1-kg/m2 genetically determined lower BMI was 0.98 [95% confidence interval (CI), 0.77 to 1.23] for a weighted allele score in the CGPS. Using 32 BMIdecreasing variants from GIANT and IGAP the causal odds ratio for Alzheimer's disease for a 1-standard deviation (SD) lower genetically determined BMI was 1.02 (95% CI, 0.86 to 1.22). Corresponding observational hazard ratios from the CGPS were 1.07 (95% CI, 1.05 to 1.09) and 1.32 (95% CI, 1.20 to 1.46) for a 1-kg/m2 and a 1-SD lower BMI, respectively. Conclusions: Genetic and hence lifelong low BMI is not associated with increased risk of Alzheimer's disease in the general population. These data suggest that low BMI is not a causal risk factor for Alzheimer's disease and that the corresponding observational association likely is explained by reverse causation or confounding.",
author = "Nordestgaard, {Liv Tybj{\ae}rg} and Anne Tybj{\ae}rg-Hansen and Nordestgaard, {B{\o}rge G.} and Ruth Frikke-Schmidt",
year = "2017",
month = jul,
doi = "10.1210/jc.2017-00195",
language = "English",
volume = "102",
pages = "2310--2320",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "7",

}

RIS

TY - JOUR

T1 - Body mass index and risk of Alzheimer's disease

T2 - A mendelian randomization study of 399,536 individuals

AU - Nordestgaard, Liv Tybjærg

AU - Tybjærg-Hansen, Anne

AU - Nordestgaard, Børge G.

AU - Frikke-Schmidt, Ruth

PY - 2017/7

Y1 - 2017/7

N2 - Context: Recently, data on 2,000,000 people established that low body mass index (BMI) is associated with increased risk of dementia. Whether this observational association reflects a causal effect remains to be clarified. Objective: Wetested the hypothesis that there is a causal association between low BMI and high risk of Alzheimer's disease. Design, Setting, and Participants: Using a Mendelian randomization approach, we studied 95,578 individuals from the Copenhagen General Population Study (CGPS) with up to 36 years of follow-up and consortia data on 303,958 individuals from the Genetic Investigation of Anthropometric Traits (GIANT) and the International Genomics of Alzheimer's Project (IGAP). Main Outcome Measure: Risk of Alzheimer's disease. Results: The causal odds ratio for a 1-kg/m2 genetically determined lower BMI was 0.98 [95% confidence interval (CI), 0.77 to 1.23] for a weighted allele score in the CGPS. Using 32 BMIdecreasing variants from GIANT and IGAP the causal odds ratio for Alzheimer's disease for a 1-standard deviation (SD) lower genetically determined BMI was 1.02 (95% CI, 0.86 to 1.22). Corresponding observational hazard ratios from the CGPS were 1.07 (95% CI, 1.05 to 1.09) and 1.32 (95% CI, 1.20 to 1.46) for a 1-kg/m2 and a 1-SD lower BMI, respectively. Conclusions: Genetic and hence lifelong low BMI is not associated with increased risk of Alzheimer's disease in the general population. These data suggest that low BMI is not a causal risk factor for Alzheimer's disease and that the corresponding observational association likely is explained by reverse causation or confounding.

AB - Context: Recently, data on 2,000,000 people established that low body mass index (BMI) is associated with increased risk of dementia. Whether this observational association reflects a causal effect remains to be clarified. Objective: Wetested the hypothesis that there is a causal association between low BMI and high risk of Alzheimer's disease. Design, Setting, and Participants: Using a Mendelian randomization approach, we studied 95,578 individuals from the Copenhagen General Population Study (CGPS) with up to 36 years of follow-up and consortia data on 303,958 individuals from the Genetic Investigation of Anthropometric Traits (GIANT) and the International Genomics of Alzheimer's Project (IGAP). Main Outcome Measure: Risk of Alzheimer's disease. Results: The causal odds ratio for a 1-kg/m2 genetically determined lower BMI was 0.98 [95% confidence interval (CI), 0.77 to 1.23] for a weighted allele score in the CGPS. Using 32 BMIdecreasing variants from GIANT and IGAP the causal odds ratio for Alzheimer's disease for a 1-standard deviation (SD) lower genetically determined BMI was 1.02 (95% CI, 0.86 to 1.22). Corresponding observational hazard ratios from the CGPS were 1.07 (95% CI, 1.05 to 1.09) and 1.32 (95% CI, 1.20 to 1.46) for a 1-kg/m2 and a 1-SD lower BMI, respectively. Conclusions: Genetic and hence lifelong low BMI is not associated with increased risk of Alzheimer's disease in the general population. These data suggest that low BMI is not a causal risk factor for Alzheimer's disease and that the corresponding observational association likely is explained by reverse causation or confounding.

U2 - 10.1210/jc.2017-00195

DO - 10.1210/jc.2017-00195

M3 - Journal article

C2 - 28609829

AN - SCOPUS:85023201304

VL - 102

SP - 2310

EP - 2320

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 7

ER -

ID: 187625437